PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Bone Metabolism10.11005/jbm.2020.27.2.1192020272119The Effect of Denosumab on Bone Mass in Super Elderly PatientsChaiho Jeong, Jeonghoon Hahttps://e-jbm.org/pdf/10.11005/jbm.2020.27.2.119, https://e-jbm.org/DOIx.php?id=10.11005/jbm.2020.27.2.119, https://e-jbm.org/DOIx.php?id=10.11005/jbm.2020.27.2.119
Clinical Pharmacology: Advances and Applications10.2147/cpaa.s303302013117Impact of denosumab on bone mass in cancer patientsAlison Stopeck, Ursa Brown-Glabermanhttps://www.dovepress.com/getfile.php?fileID=16636
Journal of Bone and Mineral Research10.1002/jbmr.24012015304657-669Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus MonkeysPaul J Kostenuik, Susan Y Smith, Rana Samadfam, Jacquelin Jolette, Lei Zhou, Michael S Ominskyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.2401, https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.2401
Nephrology Dialysis Transplantation10.1093/ndt/gfaa359202136101900-1907Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational studyRikako Hiramatsu, Yoshifumi Ubara, Naoki Sawa, Akinori Sakaihttp://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfaa359/36780472/gfaa359.pdf, http://academic.oup.com/ndt/article-pdf/36/10/1900/40448920/gfaa359.pdf, http://academic.oup.com/ndt/article-pdf/36/10/1900/40448920/gfaa359.pdf
Yearbook of Endocrinology10.1016/s0084-3741(09)79335-720092009210-212Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 TrialB.L. Clarkehttps://api.elsevier.com/content/article/PII:S0084374109793357?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084374109793357?httpAccept=text/plain
Reactions Weekly10.1007/s40278-014-8935-820141489115-15Denosumabhttp://link.springer.com/content/pdf/10.1007/s40278-014-8935-8.pdf, http://link.springer.com/article/10.1007/s40278-014-8935-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-014-8935-8
PharmacoEconomics & Outcomes News10.2165/00151234-201206660-00021201266618-8Denosumab dominates in elderly osteoporosis patientshttp://link.springer.com/content/pdf/10.2165/00151234-201206660-00021.pdf, http://link.springer.com/article/10.2165/00151234-201206660-00021/fulltext.html, http://link.springer.com/content/pdf/10.2165/00151234-201206660-00021.pdf
Journal of Bone and Mineral Research10.1002/jbmr.33762018335773-782Effect of Zoledronic Acid and Denosumab in Patients With Low Back Pain and Modic Change: A Proof-of-Principle TrialGuoqi Cai, Laura L Laslett, Dawn Aitken, Andrew Halliday, Feng Pan, Petr Otahal, Deborah Speden, Tania M Winzenberg, Graeme Joneshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.3376, https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.3376
Yearbook of Endocrinology10.1016/j.yend.2011.04.00520112011182-184Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone MassB.L. Clarkehttps://api.elsevier.com/content/article/PII:S0084374111000138?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084374111000138?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdw521.041201627vii84Effect of denosumab on change of bone resorption marker in postmenopausal breast cancer patientsShizuku Masato, Yutaka Mizuno, Yoshimi Shimizu, Toshihiro Morihttps://api.elsevier.com/content/article/PII:S092375341953873X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092375341953873X?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/27/suppl_7/mdw521.041/22971602/mdw521.041.pdf